Relmada Therapeutics Patents – Insights & Stats (Updated 2024)

Relmada Therapeutics has a total of 72 patents globally, out of which 25 have been granted. Of these 72 patents, more than 34% patents are active. The United States of America is where Relmada Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Relmada Therapeutics.

Relmada Therapeutics was founded in 2004. Relmada Therapeutics is a biotech firm that works on conditions affecting the brain and spinal cord, specifically focusing on treating major depressive disorder.

Do read about some of the most popular patents of Relmada Therapeutics which have been covered by us in this article and also you can find Relmada Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Relmada Therapeutics patent portfolio.

How many patents does Relmada Therapeutics have?

Relmada Therapeutics has a total of 72 patents globally. These patents belong to 17 unique patent families. Out of 72 patents, 25 patents are active.

How Many Patents did Relmada Therapeutics File Every Year?

Relmada Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRelmada Therapeutics Applications FiledRelmada Therapeutics Patents Granted
20231
20221
20211
202025
201916
201813
201751
201635
201511
201211

How many Relmada Therapeutics patents are Alive/Dead?

Worldwide Patents

Relmada Therapeutics Patent Portfolio

How Many Patents did Relmada Therapeutics File in Different Countries?

Relmada Therapeutics Worldwide Patent Filing

Countries in which Relmada Therapeutics Filed Patents

CountryPatent
United States of America15
Europe (EPO)8
China4
Korea (South)3
Germany3
Austria3
Canada3
Hong Kong (S.A.R.)3
Mexico2
Australia2
Singapore2
Japan2
India2
Denmark2
Israel1

Where are Research Centers of Relmada Therapeutics Patents Located?

R&D Centres of Relmada Therapeutics

10 Best Relmada Therapeutics Patents

WO2008024408A2 is the most popular patent in the Relmada Therapeutics portfolio. It has received 147 citations so far from companies like Axim Biotechnologies, 4P Therapeutics, KannaInnovations.

Below is the list of 10 most cited patents of Relmada Therapeutics:

Publication NumberCitation Count
WO2008024408A2147
WO2008024490A2135
US20090082466A1101
US20120065221A191
WO2007087452A256
WO2008033351A253
US20120178771A141
US20040209850A138
WO2008134071A136
WO2008115572A132

What are Relmada Therapeutics key innovation segments?

What Technologies are Covered by Relmada Therapeutics?

The chart below distributes patents filed by Relmada Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Relmada Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Relmada Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Relmada Therapeutics?

Related Articles

Monetago Patents – Insights and Stats (Updated 2024)

Monetago has a total of 10 patents globally, out of which none have been granted. Of these 10 patents, all the patents are inactive. The United States of America is where Monetago has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.